Welcome to Health Care POV | sign in | join
in Search


All Tags » Current Events » Molecular Diagnostics
Showing page 1 of 5 (50 total posts)
  • A Pivotal First Step

    Researchers from the Icahn School of Medicine at Mount Sinai and Harvard Medical School recently discovered a connection between a form of liver cancer and two mutations in the IDH gene. Intrahepatic cholangiocarinoma (iCCA) is the second most common form of liver cancer. Although there had previously been evidence of IDH mutations in patients ...
    Posted to ADVANCE Discourse: Lab (Weblog) on July 10, 2014
  • The Genetic ABC’s

    Imagine adding letters to the alphabet. Suddenly after centuries of working with 26 letters, there are just whole new possibilities for different words and phrases that had never been explored before. How would we use the new letters? As it turns out, research scientists at the Scripps Research institute in La Jolla, CA have been asking ...
    Posted to ADVANCE Discourse: Lab (Weblog) on May 16, 2014
  • "Missing Link"

    Type 2 diabetes has been a growing concern in the United States for several years. While the established research has pointed to two specific hormones, glucagon and insulin, as the primary factors leading to the development of the disorder in patients, researchers have discovered a third key player in a recent news release from Johns Hopkins. ...
    Posted to ADVANCE Discourse: Lab (Weblog) on April 7, 2014
  • Stem Cells and Nerve Damage

    Regenerative medicine is a field that seems like something right out of the pages of science fiction. In a recent study from the University of Pittsburgh Medical Center (UPMC), researchers studied the effect -- and subsequent success -- of stem cells derived from human muscle tissue in repairing nerve damage in mice. A UPMC press release ...
    Posted to ADVANCE Discourse: Lab (Weblog) on March 25, 2014
  • Crowdfunding MDx

    We’re all familiar with the popularity of crowdfunding websites like Kickstarter for both the largely successful and also the somewhat misguided attempts to gather funding for movies and music videos, but lately a much more serious group has turned to crowdfunding: clinical researchers. In an effort to gain additional funding for its handheld ...
    Posted to ADVANCE Discourse: Lab (Weblog) on February 5, 2014
  • Sunshine Act on Cloudy Finances

    The implementation of the Affordable Care Act, or ObamaCare, has already seen several new laws and regulatory measures introduced since its implementation, with many more soon to be on the horizon. One of these is the Sunshine Act, a law requiring public disclosure of any financial agreements between healthcare vendors and providers. Recent ...
    Posted to ADVANCE Discourse: Lab (Weblog) on January 29, 2014
  • Geisinger Partners with Regeneron Pharmaceuticals

    The influence of genetic sequencing has left its mark across the healthcare industry. In a recent partnership with Pennsylvania’s Geisinger Health System, Regeneron Pharmiceuticals, who recently came out with Eylea for age-related macular degeneration, is looking to take some of the the first substantial steps in making that vision a reality. ...
    Posted to ADVANCE Discourse: Lab (Weblog) on January 21, 2014
  • Multiple Genomes

    The concept of genetic mosaics and chimeras in terms of our individual genomes has come up before, but continued research seems to be confirming the suspicion that there is no one individual genome lately. As I discussed in the last article, “chimera” is a term used to describe “a living thing with several populations of cells with different ...
    Posted to ADVANCE Discourse: Lab (Weblog) on January 3, 2014
  • Emerging PCR trends

    Digital technology is a factor that affects almost every field across the country. Specifically, the implementation of digital counterparts to traditional tests and assays in the clinical testing industry has already started to leave a mark on the field. While the introduction of new techniques is common in the evolving backdrop of the ...
    Posted to ADVANCE Discourse: Lab (Weblog) on December 27, 2013
  • Genetics and Litigation

    In recent months, there has been a lot of litigation and government influence regarding companies offering genetic sequencing services. Following the memorable SCOTUS ruling against Myriad Genetics in June and the company’s subsequent law suit involving Ambry Genetics, the FDA joined in on further regulatory disputes with a cease-and-desist ...
    Posted to ADVANCE Discourse: Lab (Weblog) on December 11, 2013
1 2 3 4 5 Next >